B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS.
Sophia S WangClaire M VajdicMartha S LinetSusan L SlagerJenna VoutsinasAlexandra NietersDelphine CasabonneJames R CerhanWendy CozenGraciela AlarcónOtoniel Martinez-MazaElizabeth E BrownPaige M BracciJennifer TurnerHenrik HjalgrimParveen BhattiYawei ZhangBrenda M BirmannChristopher R FlowersOra PaltielElizabeth A HollyEleanor KaneDennis D WeisenburgerMarc MaynadiéPierluigi CoccoLenka ForetovaElizabeth Crabb BreenQing LanAngela R Brooks-WilsonAnneclaire J De RoosMartyn T SmithEve RomanPaolo BoffettaAnne KrickerTongzhang ZhengChristine F SkibolaJacqueline ClavelAlain MonnereauStephen J ChanockNathaniel RothmanYolanda BenaventePatricia HartgeKarin E SmedbyPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2022)
Targeted genetic (PRS) screening among population subsets with autoimmune conditions may offer opportunities for identifying those at highest risk for (and early detection from) DLBCL.